Brief: Acurx Pharmaceuticals, Inc. Announces Pricing Of $15 Million Underwritten Initial Public Offering Of Common Stock
25/06/2021 13:07
June 25 (Reuters) - Acrux Pharmaceuticals Inc ACXP.O :
* ACURX PHARMACEUTICALS, INC. ANNOUNCES PRICING OF $15
MILLION
UNDERWRITTEN INITIAL PUBLIC OFFERING OF COMMON STOCK
* SAYS INITIAL PUBLIC OFFERING OF 2.50 MILLION COMMON SHARES
PRICED AT $6.00PER SHARE
Source text for Eikon: ID:nPn9y7P3Ya
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program